{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:56:13Z","timestamp":1788260173135,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-03716-y","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T04:30:54Z","timestamp":1748320254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Probe amplifications in the Xpert MTB\/RIF Ultra assay for non-tuberculous mycobacteria identified from diabetes mellitus and chronic kidney disease patients in Ethiopia"],"prefix":"10.1038","volume":"15","author":[{"given":"Ayinalem","family":"Alemu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getu","family":"Diriba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getachew","family":"Seid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanuel","family":"Wondimu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bedo","family":"Buta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengistu","family":"Tadesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biniyam","family":"Dagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Melese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon H","family":"Mariam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nega","family":"Berhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balako","family":"Gumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"issue":"8","key":"3716_CR1","doi-asserted-by":"publisher","first-page":"e0289917","DOI":"10.1371\/journal.pone.0289917","volume":"18","author":"DA Getahun","year":"2023","unstructured":"Getahun, D. A., Layland, L. E., Hoerauf, A. & Wondale, B. Impact of the use of GeneXpert on TB diagnosis and anti-TB treatment outcome at health facilities in addis Ababa, Ethiopia in the post-millennium development years. PLoS One. 18 (8), e0289917 (2023).","journal-title":"PLoS One"},{"issue":"10","key":"3716_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.9734\/ajmah\/2023\/v21i10899","volume":"21","author":"FKB Sorvor","year":"2023","unstructured":"Sorvor, F. K. B. & Ewusie, E. A. Evaluating the impact of the GeneXpert technique on case detection and management of tuberculosis in Ghana. Asian J. Med. Health. 21 (10), 241\u2013252 (2023).","journal-title":"Asian J. Med. Health"},{"issue":"8","key":"3716_CR3","doi-asserted-by":"publisher","first-page":"899","DOI":"10.5588\/ijtld.17.0729","volume":"22","author":"WMZ Awan","year":"2018","unstructured":"Awan, W. M. Z. et al. Impact of scaling up Xpert((R)) MTB\/RIF testing for the detection of rifampicin-resistant TB cases in Karachi, Pakistan. Int. J. Tuberculosis Lung Disease: Official J. Int. Union against Tuberculosis Lung Disease. 22 (8), 899\u2013904 (2018).","journal-title":"Int. J. Tuberculosis Lung Disease: Official J. Int. Union against Tuberculosis Lung Disease"},{"key":"3716_CR4","unstructured":"WHO. Xpert MTB\/RIF Implementation Manual Technical and Operational \u2018how-to\u2019: Practical Considerations (World Health Organization, 2014)."},{"key":"3716_CR5","unstructured":"WHO. Xpert MTB\/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children (World Health Organization, 2011)."},{"issue":"9","key":"3716_CR6","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.2217\/fmb.11.84","volume":"6","author":"SD Lawn","year":"2011","unstructured":"Lawn, S. D. & Nicol, M. P. Xpert\u00ae MTB\/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol. 6 (9), 1067\u20131082 (2011). (2011).","journal-title":"Future Microbiol."},{"key":"3716_CR7","doi-asserted-by":"crossref","unstructured":"Lyu, L. et al. Evaluation of digital PCR assay in detection of M.tuberculosis IS6110 and IS1081 in tuberculosis patients plasma. BMC Infect. Dis. 20(1) (2020).","DOI":"10.1186\/s12879-020-05375-y"},{"issue":"8","key":"3716_CR8","doi-asserted-by":"publisher","first-page":"e0201934","DOI":"10.1371\/journal.pone.0201934","volume":"13","author":"F Bisognin","year":"2018","unstructured":"Bisognin, F., Lombardi, G., Lombardo, D., Re, M. C. & Dal Monte, P. Improvement of Mycobacterium tuberculosis detection by Xpert MTB\/RIF ultra: A head-to-head comparison on Xpert-negative samples. PLoS One. 13 (8), e0201934 (2018).","journal-title":"PLoS One"},{"key":"3716_CR9","first-page":"CD009593","volume":"2","author":"JS Zifodya","year":"2021","unstructured":"Zifodya, J. S. et al. Xpert ultra versus Xpert MTB\/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis. Cochrane Database Syst. Rev. 2, CD009593 (2021).","journal-title":"Cochrane Database Syst. Rev."},{"key":"3716_CR10","unstructured":"WHO.Technical report on critical concentrations for drug susceptibility testing of isoniazid and the rifamycins (rifampicin, rifabutin and rifapentine). Geneva: World Health Organization. Licence: CC BY-NC-SA 3.0 IGO. (2021)."},{"key":"3716_CR11","doi-asserted-by":"publisher","first-page":"e00686","DOI":"10.1128\/JCM.00686-18","volume":"56","author":"KCS Ng","year":"2018","unstructured":"Ng, K. C. S. et al. Xpert ultra can unambiguously identify specific Rifampin resistance-conferring mutations. J. Clin. Microbiol. 56, e00686\u2013e00618 (2018).","journal-title":"J. Clin. Microbiol."},{"key":"3716_CR12","first-page":"e00907","volume":"58","author":"Y Cao","year":"2020","unstructured":"Cao, Y. et al. Automatic identification of individual RpoB gene mutations responsible for Rifampin resistance in Mycobacterium tuberculosis by use of melting temperature signatures generated by the Xpert MTB\/RIF ultra assay. J. Clin. Microbiol. 58, e00907\u2013e00919 (2020).","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"3716_CR13","doi-asserted-by":"publisher","first-page":"115243","DOI":"10.1016\/j.diagmicrobio.2020.115243","volume":"99","author":"Y Tang","year":"2021","unstructured":"Tang, Y. et al. Probe A shown in the GeneXpert MTB\/RIF assay during the detection of Mycobacterium intracellular infections. Diagn. Microbiol. Infect. Dis. 99 (2), 115243 (2021).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"1","key":"3716_CR14","first-page":"576","volume":"39","author":"CJ Opperman","year":"2024","unstructured":"Opperman, C. J. et al. Misdiagnosis of non-tuberculous mycobacteria as tuberculous by the GeneXpert MTB\/RIF ultra: fact or fiction? S Afr. J. Infect. Dis. 39 (1), 576 (2024).","journal-title":"J. Infect. Dis."},{"key":"3716_CR15","doi-asserted-by":"publisher","first-page":"e00812","DOI":"10.1128\/mBio.00812-17","volume":"8","author":"S Chakravorty","year":"2017","unstructured":"Chakravorty, S. et al. The new Xpert MTB\/RIF ultra: improving detection of Mycobacterium tuberculosis and resistance to Rifampin in an assay suitable for point-of-care testing. mBio 8, e00812\u2013e00817 (2017).","journal-title":"mBio"},{"issue":"9","key":"3716_CR16","doi-asserted-by":"publisher","first-page":"e0275159","DOI":"10.1371\/journal.pone.0275159","volume":"17","author":"A Alemayehu","year":"2022","unstructured":"Alemayehu, A. et al. A glimpse into the genotype and clinical importance of Non tuberculous mycobacteria among pulmonary tuberculosis patients: the case of Ethiopia. PLoS One. 17 (9), e0275159 (2022).","journal-title":"PLoS One"},{"key":"3716_CR17","doi-asserted-by":"crossref","unstructured":"Koh, W. J. Nontuberculous Mycobacteria-Overview. Microbiol. Spectr. 5(1) (2017).","DOI":"10.1128\/microbiolspec.TNMI7-0024-2016"},{"issue":"3","key":"3716_CR18","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1093\/gbe\/evv035","volume":"7","author":"J Wang","year":"2015","unstructured":"Wang, J. et al. Insights on the emergence of Mycobacterium tuberculosis from the analysis of Mycobacterium kansasii. Genome Biol. Evol. 7 (3), 856\u2013870 (2015).","journal-title":"Genome Biol. Evol."},{"issue":"4","key":"3716_CR19","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciaa241","volume":"71","author":"CL Daley","year":"2020","unstructured":"Daley, C. L. et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Clin. Infect. Dis. 71 (4), e1\u2013e36 (2020).","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"3716_CR20","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s15010-017-1044-x","volume":"45","author":"Y Pang","year":"2017","unstructured":"Pang, Y., Lu, J., Su, B., Zheng, H. & Zhao, Y. Misdiagnosis of tuberculosis associated with some species of nontuberculous mycobacteria by GeneXpert MTB\/RIF assay. Infection 45 (5), 677\u2013681 (2017).","journal-title":"Infection"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03716-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03716-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03716-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T17:01:51Z","timestamp":1748710911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03716-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3716"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-03716-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18465"}}